| Product Code: ETC9967151 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Graves' Disease Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Graves' Disease Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Graves' Disease Market - Industry Life Cycle |
3.4 United States (US) Graves' Disease Market - Porter's Five Forces |
3.5 United States (US) Graves' Disease Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.6 United States (US) Graves' Disease Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
4 United States (US) Graves' Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of Graves' disease in the United States |
4.2.2 Growing awareness and diagnosis rates of autoimmune diseases |
4.2.3 Technological advancements in diagnostic tools and treatment options |
4.3 Market Restraints |
4.3.1 High cost of treatment and medications for Graves' disease |
4.3.2 Limited availability of specialized healthcare professionals for managing Graves' disease |
4.3.3 Stringent regulatory requirements for approval of new treatments |
5 United States (US) Graves' Disease Market Trends |
6 United States (US) Graves' Disease Market, By Types |
6.1 United States (US) Graves' Disease Market, By Diagnosis |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Graves' Disease Market Revenues & Volume, By Diagnosis, 2021- 2031F |
6.1.3 United States (US) Graves' Disease Market Revenues & Volume, By Ultrasound, 2021- 2031F |
6.1.4 United States (US) Graves' Disease Market Revenues & Volume, By Imaging Test, 2021- 2031F |
6.1.5 United States (US) Graves' Disease Market Revenues & Volume, By Radioactive Iodine Uptake, 2021- 2031F |
6.1.6 United States (US) Graves' Disease Market Revenues & Volume, By Blood Sample, 2021- 2031F |
6.2 United States (US) Graves' Disease Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Graves' Disease Market Revenues & Volume, By Anti-Thyroid Medication, 2021- 2031F |
6.2.3 United States (US) Graves' Disease Market Revenues & Volume, By Radioactive Iodine Therapy, 2021- 2031F |
6.2.4 United States (US) Graves' Disease Market Revenues & Volume, By Surgery, 2021- 2031F |
7 United States (US) Graves' Disease Market Import-Export Trade Statistics |
7.1 United States (US) Graves' Disease Market Export to Major Countries |
7.2 United States (US) Graves' Disease Market Imports from Major Countries |
8 United States (US) Graves' Disease Market Key Performance Indicators |
8.1 Average time to diagnosis of Graves' disease |
8.2 Patient adherence to prescribed treatment plans |
8.3 Number of research studies and clinical trials conducted for Graves' disease |
8.4 Rate of adoption of new treatment modalities |
8.5 Patient satisfaction with healthcare services for Graves' disease |
9 United States (US) Graves' Disease Market - Opportunity Assessment |
9.1 United States (US) Graves' Disease Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.2 United States (US) Graves' Disease Market Opportunity Assessment, By Treatment, 2021 & 2031F |
10 United States (US) Graves' Disease Market - Competitive Landscape |
10.1 United States (US) Graves' Disease Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Graves' Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here